Functional impact of androgen‐targeted therapy on patients with castration‐resistant prostate cancer

CONTEXT: Second‐generation androgen receptor inhibitors (ARIs) extend metastasis‐free survival, prolong overall survival, and delay symptoms when added to androgen deprivation therapy for the treatment of castration‐sensitive or castration‐resistant prostate cancer (CRPC). However, ARIs may adversel...

Descripción completa

Detalles Bibliográficos
Autores principales: Beer, Tomasz M., Shore, Neal, Morgans, Alicia, Winters‐Stone, Kerri, Wefel, Jeffrey S., George, Daniel J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
To the Journals
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579880/
https://www.ncbi.nlm.nih.gov/pubmed/36267196
http://dx.doi.org/10.1002/bco2.179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579880/
https://www.ncbi.nlm.nih.gov/pubmed/36267196
http://dx.doi.org/10.1002/bco2.179

Ejemplares similares